NBIX - Neurocrine Biosciences Inc. (NBIX) CEO Kevin Gorman on Q1 2022 Results - Earnings Call Transcript
Neurocrine Biosciences, Inc. (NBIX) Q1 2022 Earnings Conference Call May 04, 2022, 08:00 ET Company Participants Todd Tushla - VP, IR Kevin Gorman - CEO & Director Matthew Abernethy - CFO Eric Benevich - Chief Commercial Officer Eiry Roberts - Chief Medical Officer Kyle Gano - Chief Business Development and Strategy Officer Conference Call Participants Paul Matteis - Stifel, Nicolaus & Company Brian Skorney - Robert W. Baird & Co. Carter Gould - Barclays Bank Neena Bitritto-Garg - Citigroup Tazeen Ahmad - Bank of America Merrill Lynch Joshua Schimmer - Evercore ISI Anupam Rama - JPMorgan Chase & Co. Charles Duncan - Cantor Fitzgerald & Co. Philip Nadeau - Cowen and Company Jeff Hung - Morgan Stanley Chris Shibutani - Goldman Sachs Group Jay Olson - Oppenheimer Laura Chico - Wedbush Securities Marc Goodman - SVB Leerink Vamil Divan - Mizuho Securities Myles Minter - William Blair & Company Yatin
For further details see:
Neurocrine Biosciences, Inc. (NBIX) CEO Kevin Gorman on Q1 2022 Results - Earnings Call Transcript